4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-22-033477
Director sold 1,126 shares at an average $55.32 ($62,291)
- Director acquired 626 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOLGER JOHN C Director | 2022-05-31 | Option exercise | +313 | $3.93 | $1,229 | 4,313 | D: show line 1 in the form |
| BOLGER JOHN C Director | 2022-05-31 | Sale | −313 | $55.32 | $17,315 | 4,000 | D: show line 2 in the form |
| BOLGER JOHN C Director | 2022-05-31 | Option exercise | +313 | $5.81 | $1,818 | 4,313 | D: show line 3 in the form |
| BOLGER JOHN C Director | 2022-05-31 | Sale | −313 | $55.44 | $17,351 | 4,000 | D: show line 4 in the form |
| BOLGER JOHN C Director | 2022-05-31 | Sale | −500 | $55.25 | $27,625 | 3,500 | D: show line 5 in the form |
| Open-market sales · 1,126 sh · avg $55.32 · $62,291 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOLGER JOHN C Director | 2022-05-31 | Option exercise · Stock Option (Right to Buy) | −313 | 0 | D: show line 6 in the form | ||
| BOLGER JOHN C Director | 2022-05-31 | Option exercise · Stock Option (Right to Buy) | −313 | 1,250 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…